SL 0101-1 |
| Katalog-Nr.GC16313 |
SL 0101-1 (SL0101), ein aus der tropischen Pflanze F. Refracta isoliertes Kaempferol-Glycosid, ist ein zellgÄngiger, selektiver, reversibler, ATP-kompetitiver p90 Ribosomal S6 Kinase (RSK)-Inhibitor mit einem IC50 von 89 nM. SL 0101-1 (SL0101) ist ein selektiver RSK1/2-Inhibitor mit einem Ki von 1 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 77307-50-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SL 0101-1 (SL0101), a kaempferol glycoside, isolated from the tropical plant F. refracta, is a cell-permeable, selective, reversible, ATP-competitive p90 Ribosomal S6 Kinase (RSK) inhibitor, with an IC50 of 89 nM. Shows proliferation inhibition in human breast cancer cell line MCF-7 and produces a cell cycle block in G1 phase[1].
References:
[1]. Smith JA, et al. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 2005 Feb 1;65(3):1027-34.
Average Rating: 5 (Based on Reviews and 1 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *